NIH Technology Opportunity Webinar: Bone Marrow Mesenchymal Stem Cell (BMSC)-Derived Exosomes for the Treatment of Glaucoma

Register to attend a free NIH webinar. Attendees will learn about a new method for treating glaucoma using exosomes derived from bone marrow-derived mesenchymal stem cells (BMSC).

Webinar Overview:
The inventors will discuss their discovery that BMSC‐derived exosome administration for glaucoma may confer a significant neuroprotective effect for retinal ganglion cells (RGCs) and prevent vision loss, and how their isolated BMSC-derived exosomes have several immediate advantages for clinical translation compared to potential whole-cell (stem cell) therapies currently being used to treat glaucoma.